tiprankstipranks
Trending News
More News >
Humana Inc (HUM)
NYSE:HUM
US Market
Advertisement

Humana (HUM) Stock Forecast & Price Target

Compare
2,500 Followers
See the Price Targets and Ratings of:

HUM Analyst Ratings

Moderate Buy
17Ratings
Moderate Buy
7 Buy
10 Hold
0 Sell
Based on 17 analysts giving stock ratings to
Humana
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

HUM Stock 12 Month Forecast

Average Price Target

$289.71
▲(21.74%Upside)
Based on 17 Wall Street analysts offering 12 month price targets for Humana in the last 3 months. The average price target is $289.71 with a high forecast of $348.00 and a low forecast of $244.00. The average price target represents a 21.74% change from the last price of $237.98.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"229":"$229","264":"$264","299":"$299","334":"$334","369":"$369"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":348,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$348.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":289.71,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$289.71</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":244,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$244.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[229,264,299,334,369],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,252.58,259.92,267.26,274.6,281.94,289.28000000000003,296.62,303.96000000000004,311.3,318.64,325.98,333.32,340.65999999999997,{"y":348,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,252.58,255.43615384615384,258.2923076923077,261.14846153846156,264.00461538461536,266.8607692307692,269.7169230769231,272.57307692307694,275.42923076923074,278.2853846153846,281.14153846153846,283.9976923076923,286.8538461538461,{"y":289.71,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,252.58,251.92000000000002,251.26000000000002,250.60000000000002,249.94,249.28,248.62,247.96,247.3,246.64000000000001,245.98,245.32,244.66,{"y":244,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":368.58,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":354.26,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":349.81,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":276.54,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":258,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 28, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":290.08,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 36, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":251.95,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":291.19,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":268.54,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":263.76,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":255.1,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":230.54,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":252.58,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$348.00Average Price Target$289.71Lowest Price Target$244.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on HUM
TipRanks AITipRanks
Not Ranked
TipRanks
$267
Buy
12.19%
Upside
Reiterated
07/26/25
Humana's overall stock score reflects strong financial performance and strategic growth initiatives, bolstered by a new credit agreement enhancing financial flexibility. However, technical indicators and regulatory uncertainties pose challenges. The balanced valuation and positive earnings call sentiment further support the company's prospects, despite external risks.
Robert W. Baird Analyst forecast on HUM
Michael HaRobert W. Baird
Robert W. Baird
$300$297
Hold
24.80%
Upside
Reiterated
07/25/25
Humana price target lowered to $297 from $300 at BairdHumana price target lowered to $297 from $300 at Baird
UBS
$285
Hold
19.76%
Upside
Reiterated
07/21/25
UBS Keeps Their Hold Rating on Humana (HUM)UBS analyst AJ Rice reiterated a Neutral rating and $285.00 price target on Humana (NYSE: HUM).
TD Cowen
$268
Hold
12.61%
Upside
Reiterated
07/21/25
TD Cowen Sticks to Its Hold Rating for Humana (HUM)
Morgan Stanley Analyst forecast on HUM
Erin WrightMorgan Stanley
Morgan Stanley
$290
Hold
21.86%
Upside
Reiterated
07/18/25
MA Stars loss for Humana baked into earnings bridge, says Morgan StanleyMA Stars loss for Humana baked into earnings bridge, says Morgan Stanley
Raymond James Analyst forecast on HUM
John RansomRaymond James
Raymond James
$340
Buy
42.87%
Upside
Reiterated
07/18/25
Humana (HUM) Gets a Buy from Raymond James
Mizuho Securities Analyst forecast on HUM
Ann HynesMizuho Securities
Mizuho Securities
$316
Buy
32.78%
Upside
Reiterated
07/18/25
Humana loses CMS lawsuit, as expected, says MizuhoHumana loses CMS lawsuit, as expected, says Mizuho
Leerink Partners Analyst forecast on HUM
Whit MayoLeerink Partners
Leerink Partners
$271
Hold
13.88%
Upside
Reiterated
07/18/25
Leerink Partners Sticks to Their Hold Rating for Humana (HUM)
Guggenheim Analyst forecast on HUM
Jason CassorlaGuggenheim
Guggenheim
$326
Buy
36.99%
Upside
Reiterated
07/18/25
Humana (HUM) Gets a Buy from Guggenheim
Wells Fargo Analyst forecast on HUM
Stephen BaxterWells Fargo
Wells Fargo
$348
Buy
46.23%
Upside
Reiterated
07/18/25
Humana investors assumed low odds of Stars suit success, says Wells FargoHumana investors assumed low odds of Stars suit success, says Wells Fargo
Barclays
$500$268
Hold
12.61%
Upside
Reiterated
07/18/25
Humana can refile Stars lawsuit at later date, says BarclaysHumana can refile Stars lawsuit at later date, says Barclays
Truist Financial Analyst forecast on HUM
David S MacdonaldTruist Financial
Truist Financial
$280$260
Hold
9.25%
Upside
Reiterated
07/16/25
Humana price target lowered to $260 from $280 at TruistHumana price target lowered to $260 from $280 at Truist
Bernstein Analyst forecast on HUM
Lance WilkesBernstein
Bernstein
$313$269
Buy
13.03%
Upside
Reiterated
07/16/25
Bernstein Remains a Buy on Humana (HUM)
RBC Capital Analyst forecast on HUM
Ben HendrixRBC Capital
RBC Capital
$283
Buy
18.92%
Upside
Reiterated
07/14/25
RBC Capital Sticks to Their Buy Rating for Humana (HUM)
Cantor Fitzgerald Analyst forecast on HUM
Sarah JamesCantor Fitzgerald
Cantor Fitzgerald
$290
Hold
21.86%
Upside
Reiterated
06/17/25
Cantor Fitzgerald Sticks to Their Hold Rating for Humana (HUM)
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on HUM
TipRanks AITipRanks
Not Ranked
TipRanks
$267
Buy
12.19%
Upside
Reiterated
07/26/25
Humana's overall stock score reflects strong financial performance and strategic growth initiatives, bolstered by a new credit agreement enhancing financial flexibility. However, technical indicators and regulatory uncertainties pose challenges. The balanced valuation and positive earnings call sentiment further support the company's prospects, despite external risks.
Robert W. Baird Analyst forecast on HUM
Michael HaRobert W. Baird
Robert W. Baird
$300$297
Hold
24.80%
Upside
Reiterated
07/25/25
Humana price target lowered to $297 from $300 at BairdHumana price target lowered to $297 from $300 at Baird
UBS
$285
Hold
19.76%
Upside
Reiterated
07/21/25
UBS Keeps Their Hold Rating on Humana (HUM)UBS analyst AJ Rice reiterated a Neutral rating and $285.00 price target on Humana (NYSE: HUM).
TD Cowen
$268
Hold
12.61%
Upside
Reiterated
07/21/25
TD Cowen Sticks to Its Hold Rating for Humana (HUM)
Morgan Stanley Analyst forecast on HUM
Erin WrightMorgan Stanley
Morgan Stanley
$290
Hold
21.86%
Upside
Reiterated
07/18/25
MA Stars loss for Humana baked into earnings bridge, says Morgan StanleyMA Stars loss for Humana baked into earnings bridge, says Morgan Stanley
Raymond James Analyst forecast on HUM
John RansomRaymond James
Raymond James
$340
Buy
42.87%
Upside
Reiterated
07/18/25
Humana (HUM) Gets a Buy from Raymond James
Mizuho Securities Analyst forecast on HUM
Ann HynesMizuho Securities
Mizuho Securities
$316
Buy
32.78%
Upside
Reiterated
07/18/25
Humana loses CMS lawsuit, as expected, says MizuhoHumana loses CMS lawsuit, as expected, says Mizuho
Leerink Partners Analyst forecast on HUM
Whit MayoLeerink Partners
Leerink Partners
$271
Hold
13.88%
Upside
Reiterated
07/18/25
Leerink Partners Sticks to Their Hold Rating for Humana (HUM)
Guggenheim Analyst forecast on HUM
Jason CassorlaGuggenheim
Guggenheim
$326
Buy
36.99%
Upside
Reiterated
07/18/25
Humana (HUM) Gets a Buy from Guggenheim
Wells Fargo Analyst forecast on HUM
Stephen BaxterWells Fargo
Wells Fargo
$348
Buy
46.23%
Upside
Reiterated
07/18/25
Humana investors assumed low odds of Stars suit success, says Wells FargoHumana investors assumed low odds of Stars suit success, says Wells Fargo
Barclays
$500$268
Hold
12.61%
Upside
Reiterated
07/18/25
Humana can refile Stars lawsuit at later date, says BarclaysHumana can refile Stars lawsuit at later date, says Barclays
Truist Financial Analyst forecast on HUM
David S MacdonaldTruist Financial
Truist Financial
$280$260
Hold
9.25%
Upside
Reiterated
07/16/25
Humana price target lowered to $260 from $280 at TruistHumana price target lowered to $260 from $280 at Truist
Bernstein Analyst forecast on HUM
Lance WilkesBernstein
Bernstein
$313$269
Buy
13.03%
Upside
Reiterated
07/16/25
Bernstein Remains a Buy on Humana (HUM)
RBC Capital Analyst forecast on HUM
Ben HendrixRBC Capital
RBC Capital
$283
Buy
18.92%
Upside
Reiterated
07/14/25
RBC Capital Sticks to Their Buy Rating for Humana (HUM)
Cantor Fitzgerald Analyst forecast on HUM
Sarah JamesCantor Fitzgerald
Cantor Fitzgerald
$290
Hold
21.86%
Upside
Reiterated
06/17/25
Cantor Fitzgerald Sticks to Their Hold Rating for Humana (HUM)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Humana

1 Month
xxx
Success Rate
23/37 ratings generated profit
62%
Average Return
+0.90%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 62.16% of your transactions generating a profit, with an average return of +0.90% per trade.
3 Months
xxx
Success Rate
25/37 ratings generated profit
68%
Average Return
+2.04%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 67.57% of your transactions generating a profit, with an average return of +2.04% per trade.
1 Year
Success Rate
21/37 ratings generated profit
57%
Average Return
+3.54%
reiterated a buy rating 3 months ago
Copying Michael Wiederhorn's trades and holding each position for 1 Year would result in 56.76% of your transactions generating a profit, with an average return of +3.54% per trade.
2 Years
xxx
Success Rate
26/37 ratings generated profit
70%
Average Return
+9.50%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 70.27% of your transactions generating a profit, with an average return of +9.50% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

HUM Analyst Recommendation Trends

Rating
Mar 25
Apr 25
May 25
Jun 25
Jul 25
Strong Buy
0
0
0
1
3
Buy
9
13
14
19
21
Hold
18
25
18
31
27
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
27
38
32
51
51
In the current month, HUM has received 24 Buy Ratings, 27 Hold Ratings, and 0 Sell Ratings. HUM average Analyst price target in the past 3 months is 289.71.
Each month's total comprises the sum of three months' worth of ratings.

HUM Financial Forecast

HUM Earnings Forecast

Next quarter’s earnings estimate for HUM is $5.92 with a range of $5.65 to $8.28. The previous quarter’s EPS was $11.58. HUM beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 45.65% of the time in the same period. In the last calendar year HUM has Preformed in-line its overall industry.
Next quarter’s earnings estimate for HUM is $5.92 with a range of $5.65 to $8.28. The previous quarter’s EPS was $11.58. HUM beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 45.65% of the time in the same period. In the last calendar year HUM has Preformed in-line its overall industry.

HUM Sales Forecast

Next quarter’s sales forecast for HUM is $31.87B with a range of $31.53B to $32.35B. The previous quarter’s sales results were $32.11B. HUM beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 53.04% of the time in the same period. In the last calendar year HUM has Preformed in-line its overall industry.
Next quarter’s sales forecast for HUM is $31.87B with a range of $31.53B to $32.35B. The previous quarter’s sales results were $32.11B. HUM beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 53.04% of the time in the same period. In the last calendar year HUM has Preformed in-line its overall industry.

HUM Stock Forecast FAQ

What is HUM’s average 12-month price target, according to analysts?
Based on analyst ratings, Humana Inc’s 12-month average price target is 289.71.
    What is HUM’s upside potential, based on the analysts’ average price target?
    Humana Inc has 21.74% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is HUM a Buy, Sell or Hold?
          Humana Inc has a consensus rating of Moderate Buy which is based on 7 buy ratings, 10 hold ratings and 0 sell ratings.
            What is Humana Inc’s price target?
            The average price target for Humana Inc is 289.71. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $348.00 ,the lowest forecast is $244.00. The average price target represents 21.74% Increase from the current price of $237.98.
              What do analysts say about Humana Inc?
              Humana Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 17 Wall Streets Analysts.
                How can I buy shares of HUM?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis